Epitomee slumps as Nestle nixes marketing weight loss pill
Nestlé says the trial results did not meet the full minimal terms set in the licensing agreement.
Source: globes.co.il
Dan Hashimshony News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dan Hashimshony. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dan Hashimshony Today - Breaking & Trending Today
Epitomee jumps after positive weight loss pill trial
The Israeli company has developed a pill that swells in the stomach, creates a sense of satiation and then disintegrates.
Source: globes.co.il
Epitomee Medical announced the completion of $51 million IPO on the Tel Aviv Stock Exchange; The offering was made at a pre-money valuation of $200 million
/PRNewswire/ -- Epitomee Medical (TASE: EPIT), the Israel-based bio-medical company, announced this morning the completion of its Initial Public Offering on...
Source: prnewswire.com
Epitomee Medical announced the completion of $51 million IPO on the Tel Aviv Stock Exchange; The offering was made at a pre-money valuation of $200 million
/PRNewswire/ -- Epitomee Medical (TASE: EPIT), the Israel-based bio-medical company, announced this morning the completion of its Initial Public Offering on...
Source: prnewswire.com
Shimon Eckhouse brings Epitomee Medical to TASE
The flotation is Eckhouse's second in six months. Epitomee has developed a pill for treating obesity and drug delivery.
Source: globes.co.il